Legacy Wealth Asset Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
VCM
MAM
JWS
GI
FFA
EWP
GWM
MGI
TFA
RWS
Legacy Wealth Asset Management's GMAB Position: Q3 2026 in Review
Legacy Wealth Asset Management reduced its Genmab (GMAB) stake by 2.2% in Q3 2026, selling an estimated $70.4K and leaving 99,937 shares worth $3.57M. The position accounts for 0.78% of the portfolio, ranked #19.
Legacy Wealth Asset Management first reported a position in GMAB in Q3 2022 and has held it in 17 quarters since. 13 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Legacy Wealth Asset Management held 99,937 shares of Genmab worth $3.57M as of Q3 2026.
- Legacy Wealth Asset Management sold 2,227 Genmab shares in Q3 2026, an estimated $70.4K.
- Genmab made up 0.78% of Legacy Wealth Asset Management's portfolio in Q3 2026, its #19 holding.
- Legacy Wealth Asset Management first reported a position in Genmab in Q3 2022 and has held it in 17 quarters since.
- 13 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Legacy Wealth Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.